오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

novartis pharmaceuticals australia pty ltd - carbamazepine, quantity: 20 mg/ml - oral liquid, suspension - excipient ingredients: hyetellose; methyl hydroxybenzoate; purified water; dispersible cellulose; propyl hydroxybenzoate; sorbitol solution (70 per cent) (non-crystallising); peg-8 stearate; sorbic acid; propylene glycol; saccharin sodium; flavour - 1. epilepsy: complex or simple partial seizures (with or without loss of consciousness) with or without secondary generalisation; generalised tonic-clonic seizures; mixed seizure patterns incorporating the above. tegretol is suitable for monotherapy and combination therapy. tegretol is usually not effective in absence seizures, atonic seizures and myoclonic seizures and should not be used for status epilepticus (see "precautions"). 2. trigeminal neuralgia: for relief of pain in idiopathic trigeminal neuralgia and trigeminal neuralgia due to multiple sclerosis; and in idiopathic glossopharyngeal neuralgia. (tegretol is not a simple analgesic and is not intended for trivial facial pain or headache). 3. mania and bipolar affective disorders: treatment of mania and maintenance treatment of bipolar affective disorders to prevent or attenuate recurrence.

오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

sun pharma anz pty ltd - cefaclor monohydrate, quantity: 52.45 mg/ml (equivalent: cefaclor, qty 50 mg/ml) - oral liquid, powder for - excipient ingredients: citric acid; colloidal anhydrous silica; xanthan gum; sucrose; sodium benzoate; allura red ac; sodium citrate dihydrate; flavour; potable water; simethicone; cetostearyl alcohol - infections due to susceptible microorganisms. lower respiratory infections, including pneumonia, bronchitis and exacerbations of chronic bronchitis. upper respiratory tract infections, including pharyngitis and tonsillitis and otitis media. skin and skin structure infections. urinary tract infections, including pyelonephritis and cystitis. note: penicillin is the usual drug of choice in the treatment and prevention of streptococcal infections, including the prophylaxis of rheumatic fever. cefaclor appears to be as effective as phenoxymethylpenicillin in the eradication of streptococci from the nasopharynx; however, substantial data establishing the efficacy of cefaclor in the subsequent prevention of rheumatic fever are not available at present. appropriate culture and susceptibility studies should be performed to determine susceptibility of the causative organism to cefaclor.

오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

sun pharma anz pty ltd - cefaclor monohydrate, quantity: 26.23 mg/ml (equivalent: cefaclor, qty 25 mg/ml) - oral liquid, powder for - excipient ingredients: citric acid; xanthan gum; sucrose; sodium citrate dihydrate; colloidal anhydrous silica; sodium benzoate; allura red ac; flavour; potable water; simethicone; cetostearyl alcohol - infections due to susceptible microorganisms. lower respiratory infections, including pneumonia, bronchitis and exacerbations of chronic bronchitis. upper respiratory tract infections, including pharyngitis and tonsillitis and otitis media. skin and skin structure infections. urinary tract infections, including pyelonephritis and cystitis. note: penicillin is the usual drug of choice in the treatment and prevention of streptococcal infections, including the prophylaxis of rheumatic fever. cefaclor appears to be as effective as phenoxymethylpenicillin in the eradication of streptococci from the nasopharynx; however, substantial data establishing the efficacy of cefaclor in the subsequent prevention of rheumatic fever are not available at present. appropriate culture and susceptibility studies should be performed to determine susceptibility of the causative organism to cefaclor.

오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

viiv healthcare pty ltd - lamivudine, quantity: 10 mg/ml - oral liquid, solution - excipient ingredients: citric acid; sodium hydroxide; propyl hydroxybenzoate; purified water; hydrochloric acid; sodium citrate dihydrate; methyl hydroxybenzoate; propylene glycol; sucrose; flavour - 3tc (lamivudine) in combination with other antiretroviral agents is indicated for the treatment of hiv infected adults and children.

오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

viatris pty ltd - amoxicillin trihydrate, quantity: 50 mg/ml - oral liquid, powder for - excipient ingredients: colloidal anhydrous silica; silicon dioxide; disodium edetate; sodium benzoate; xanthan gum; saccharin sodium; sorbitol; flavour - indications as at 6 november 2003: cilamox is indicated for the treatment of infections due to susceptible strains of the sensitive organisms. gram-negative: h. influenzae, e coli, pr. mirabilis, and n. gonorrhoeae. gram-positive: streptococcus species, s. pneumoniae, non-penicllinase producing staphlococci and bacillus anthracis. note 1: cilamox may be useful in instituting therapy prior to bacteriology; however, bacteriological studies to determine the causative organisms and their sensitivity to cilamox should be performed. note 2: penicillins are now generally regarded only as adjunctive to some other established first-line antibiotic therapy in the treatment and post-exposure prophylaxis of anthrax, because of concerns of constitutive and inducible beta-lactamase in bacillus anthracis. if use of amoxycillin is contemplated, appropriate bacteriological studies must be performed by a reliable and established test method. amoxycillin may then be suitable if the specific b. anthracis strain has been shown definitively to be sensitive to penicillin/amaxycillin.

오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

pharmacor pty ltd - guaifenesin, quantity: 20 mg/ml; bromhexine hydrochloride, quantity: 0.6 mg/ml - oral liquid - excipient ingredients: peg-40 hydrogenated castor oil; xanthan gum; saccharin sodium; potassium sorbate; glycerol; purified water; ethyl maltol; citric acid; propylene glycol; flavour - expectorant and mucolytic for the symptomatic relief of productive chesty coughs.

오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

johnson & johnson pacific pty ltd - guaifenesin, quantity: 20 mg/ml; bromhexine hydrochloride, quantity: 0.8 mg/ml - oral liquid, solution - excipient ingredients: glycerol; citric acid; sorbitol solution (70 per cent) (non-crystallising); propylene glycol; sucralose; menthol; purified water; sodium benzoate; saccharin sodium; flavour - relieves heavy chesty coughs. helps loosen and relieve chest congestion. loosens and thins phlegm. assists with the removal of mucus and phlegm. provides symptomatic relief from congested chests and coughs due to the common cold.

오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - guaifenesin, quantity: 20 mg/ml; bromhexine hydrochloride, quantity: 0.6 mg/ml - oral liquid - excipient ingredients: citric acid; saccharin sodium; xanthan gum; purified water; propylene glycol; ethyl maltol; glycerol; potassium sorbate; peg-40 hydrogenated castor oil; flavour - expectorant and mucolytic for the symptomatic relief of productive chesty coughs.

오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

soul pattinson manufacturing pty ltd - guaifenesin, quantity: 20 mg/ml; bromhexine hydrochloride, quantity: 0.6 mg/ml - oral liquid - excipient ingredients: glycerol; citric acid; saccharin sodium; purified water; potassium sorbate; peg-40 hydrogenated castor oil; propylene glycol; ethyl maltol; xanthan gum; flavour - expectorant and mucolytic for the symptomatic relief of productive chesty coughs.

오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

soul pattinson manufacturing pty ltd - guaifenesin, quantity: 20 mg/ml; bromhexine hydrochloride, quantity: 0.6 mg/ml - oral liquid - excipient ingredients: xanthan gum; potassium sorbate; glycerol; peg-40 hydrogenated castor oil; saccharin sodium; propylene glycol; purified water; ethyl maltol; citric acid; flavour - expectorant and mucolytic for the symptomatic relief of productive chesty coughs.